RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Major Pharmaceuticals Levothyroxine 150 mcg Recall

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed

Updated July 13, 2026

Major Pharmaceuticals is recalling Levothyroxine Sodium Tablets 150 mcg because some batches contain less active ingredient than labeled, which means they may not work properly to treat thyroid conditions.

Is the Major Pharmaceuticals recalled? Yes. This product was recalled by FDA on July 13, 2026. Details below.

What is recalled

Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), in 10-tablet unit dose blister packs per carton (Rx only). Packaged and distributed by Major Pharmaceuticals, Indianapolis, IN 46268. Distributed by Cardinal Health, Dublin, OH 43017. NDC bag code 55154-3563-0; NDC blister code 0904-6956-61.

Am I affected

You are affected if you have a prescription Levothyroxine Sodium 150 mcg tablet from Major Pharmaceuticals in a 10-tablet blister pack with NDC codes 55154-3563-0 (bag) or 0904-6956-61 (blister).

What to do right now

Do not take any remaining doses. Contact your pharmacist or doctor immediately to get a replacement prescription or supply of Levothyroxine Sodium from an unaffected batch.

The hazard

Subpotent Drug

Brands affected

Major Pharmaceuticals
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0711-2026
Classification
Class II
Recalled
July 13, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls